NOVARTIS AG's ticker is and the CUSIP is H5820Q150. A total of 3 filers reported holding NOVARTIS AG in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,427 | +2.3% | 130,847 | +0.2% | 0.32% | +14.3% |
Q2 2023 | $13,131 | +7.4% | 130,534 | -2.1% | 0.28% | +10.2% |
Q1 2023 | $12,221 | -97.5% | 133,294 | +2246.7% | 0.25% | +440.4% |
Q3 2020 | $494,000 | -18.6% | 5,680 | -18.6% | 0.05% | -27.7% |
Q2 2020 | $607,000 | +5.4% | 6,980 | 0.0% | 0.06% | -19.8% |
Q1 2020 | $576,000 | -13.0% | 6,980 | 0.0% | 0.08% | +5.2% |
Q4 2019 | $662,000 | – | 6,980 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Joel Isaacson & Co., LLC | 15,718 | $1,483,000 | 0.45% |
CHICKASAW CAPITAL MANAGEMENT LLC | 29,800 | $2,800,000 | 0.09% |
CANANDAIGUA NATIONAL BANK & TRUST CO | 2,400 | $226,000 | 0.08% |
Geneva Advisors, LLC | 15,980 | $1,509,000 | 0.03% |
Cullen Capital Management, LLC | 10,900 | $1,028,000 | 0.03% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 5,200 | $491,000 | 0.01% |